Xiaoli Feng

Xiaoli Feng began their career in 2012 at Amgen as a Senior Scientist in the Cardiometabolic Disorders department. Xiaoli was quickly promoted to Principal Scientist/Global Research Lead/Project Team Lead in the same department. In 2022, they moved to Septerna as the Director of Disease Biology and Biomarker Development.

Xiaoli Feng has attended the University of California, Los Angeles and Zhejiang University.